Chandan Healthcare Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift

Price Movement and Market Context

On 29 Jun 2026, Chandan Healthcare’s share price closed at ₹244.65, up from the previous close of ₹235.25. The intraday range saw a low of ₹242.00 and a high of ₹254.80, indicating some volatility but an overall positive price momentum. However, the stock remains significantly below its 52-week high of ₹358.00, while comfortably above its 52-week low of ₹184.50. This range highlights the stock’s susceptibility to market swings within the hospital sector, which itself is navigating a challenging macroeconomic environment.

Technical Trend Evolution

The technical trend for Chandan Healthcare has shifted from bearish to mildly bearish, signalling a tentative improvement but not a full reversal of negative momentum. This subtle change suggests that while selling pressure has eased, the stock has yet to establish a robust bullish trend.

MACD Analysis

The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly timeframe, indicating that the short-term momentum is still under pressure. The monthly MACD does not provide a clear signal, reflecting a neutral stance over the longer term. This divergence between weekly and monthly MACD readings suggests that while short-term traders may remain cautious, longer-term investors might await more definitive signals before committing.

RSI and Momentum Indicators

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This absence of overbought or oversold conditions implies that the stock is not experiencing extreme momentum in either direction, reinforcing the notion of a mild technical transition rather than a decisive breakout or breakdown.

Moving Averages and Bollinger Bands

Daily moving averages are mildly bearish, indicating that the stock price is slightly below key short-term averages, which could act as resistance. The weekly Bollinger Bands also suggest a mildly bearish outlook, with the price trading near the lower band, hinting at subdued volatility but a potential for a rebound if buying interest strengthens.

Additional Technical Signals

The Know Sure Thing (KST) indicator on the weekly chart has turned mildly bullish, signalling a possible early stage of upward momentum. Similarly, the Dow Theory assessment shows a mildly bullish weekly trend but a mildly bearish monthly trend, underscoring the mixed signals across different time horizons. On-Balance Volume (OBV) remains mildly bearish on both weekly and monthly charts, indicating that volume trends have not yet confirmed a sustained buying interest.

Comparative Returns and Market Performance

Chandan Healthcare’s recent returns reveal a mixed performance relative to the broader Sensex index. Over the past week, the stock surged by 18.42%, significantly outperforming the Sensex’s decline of 0.46%. Over one month, the stock gained 4.57%, slightly ahead of the Sensex’s modest 0.10% rise. However, year-to-date (YTD) returns tell a different story, with the stock down 24.62% compared to the Sensex’s 7.94% decline. Over the past year, Chandan Healthcare has rebounded with a 23.75% gain, outperforming the Sensex’s 4.71% loss. Longer-term data is unavailable, but the stock’s micro-cap status and sector-specific challenges likely contribute to its volatility and divergence from broader market trends.

Mojo Score and Analyst Ratings

MarketsMOJO assigns Chandan Healthcare a Mojo Score of 45.0, categorising it as a Sell with a micro-cap market cap grade. This rating reflects the stock’s current technical weaknesses and fundamental challenges within the hospital sector. The company was previously not rated, indicating a recent assessment that has downgraded its outlook. Investors should weigh this cautious stance against the stock’s sporadic price rallies and technical signals that hint at potential recovery phases.

Sector and Industry Context

Operating within the hospital industry, Chandan Healthcare faces sector-specific headwinds including regulatory pressures, rising operational costs, and competitive dynamics. These factors contribute to the stock’s technical volatility and underscore the importance of monitoring momentum indicators closely. The mixed technical signals suggest that while short-term trading opportunities may arise, longer-term investors should remain vigilant and consider broader sector trends before increasing exposure.

Investor Takeaway

Chandan Healthcare Ltd’s current technical profile is characterised by a cautious shift from bearishness to a mildly bearish stance, with several indicators offering mixed signals. The weekly MACD and OBV remain bearish, while the KST and Dow Theory weekly readings suggest nascent bullish momentum. The RSI’s neutral position and mildly bearish moving averages further complicate the outlook.

Investors should consider the stock’s recent strong weekly and monthly price gains against its longer-term underperformance relative to the Sensex. The micro-cap nature of the company adds an additional layer of risk and volatility. Given the MarketsMOJO Sell rating and a Mojo Score of 45.0, a conservative approach is advisable, with close monitoring of technical indicators for confirmation of a sustained trend reversal.

In summary, while short-term momentum appears to be improving, Chandan Healthcare has yet to demonstrate a convincing technical turnaround. Investors seeking exposure to the hospital sector may wish to explore alternative opportunities with stronger technical and fundamental profiles.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →